Alere Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10,000

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.1B

Alere General Information

Description

Manufacturer of consumer and professional medical diagnostic products designed for detection of diseases and conditions within its areas of focus. The company's medical diagnostic products produces a range of vitamins and nutritional supplements for cardiology, women's health, oncology, infectious disease and drugs of abuse enabling patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home.

Contact Information

Website
www.alere.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 51 Sawyer Road
  • Suite 200
  • Waltham, MA 02453
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
Abbott
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 51 Sawyer Road
  • Suite 200
  • Waltham, MA 02453
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 03-Oct-2017 $7.1B Completed Profitable
17. Debt Refinancing 11-Jun-2015 Completed Generating Revenue
16. Merger/Acquisition 28-Oct-2014 Completed Generating Revenue
15. Debt Refinancing 13-May-2013 Completed Generating Revenue
14. Debt Refinancing 19-Feb-2013 Completed Generating Revenue
13. Debt Refinancing 28-Nov-2012 Completed Startup
12. Debt - Acquisition 28-Mar-2012 Completed Startup
11. Debt Refinancing 07-Dec-2011 Completed Startup
10. Share Repurchase 30-Jun-2011 $2.1B $2.25B Completed Startup
9. General Corporate Purpose 14-Sep-2010 $400M $150M Completed Startup
To view Alere’s complete valuation and funding history, request access »

Alere Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of consumer and professional medical diagnostic products designed for detection of diseases and conditions
Diagnostic Equipment
Waltham, MA
10,000 As of 2017

Holzgerlingen, Germany
 

Cape Town, South Africa
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alere Competitors (20)

One of Alere’s 20 competitors is Curetis, a Private Equity-Backed company based in Holzgerlingen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curetis Private Equity-Backed Holzgerlingen, Germany
CapeRay Formerly VC-backed Cape Town, South Africa
BioGenex Laboratories Corporation Fremont, CA
Heska Private Equity-Backed Loveland, CO
ELITechGroup Formerly PE-Backed Puteaux, France
You’re viewing 5 of 20 competitors. Get the full list »

Alere Patents

  • 838

    Total Documents Applications and Grants

  • Total Patents Families

  • 264

    Granted

  • 32

    Pending

  • Expiring in next 12 mo

Alere Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180268923-A1 Biometric confirmation of sample integrity Inactive 25-Sep-2015
US-20180030516-A1 Microbiome diagnostics Inactive 27-Feb-2015
EP-3262215-A1 Microbiome diagnostics Inactive 27-Feb-2015
EP-3262215-A4 Microbiome diagnostics Inactive 27-Feb-2015
EP-2829540-A1 Synthesis of substituted aminopyridines Inactive 26-Jul-2013 C07D403/12
To view Alere’s complete patent history, request access »

Alere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alere Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crawley Ventures Venture Capital Minority
Optum Corporation Majority
Skywood Ventures Venture Capital Minority
To view Alere’s complete investors history, request access »

Alere Investments & Acquisitions (55)

Alere’s most recent deal was a Merger/Acquisition with European Drug Testing Service for . The deal was made on 22-Jan-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
European Drug Testing Service 22-Jan-2016 Merger/Acquisition Other Healthcare Services
US Diagnostics 10-Jul-2015 Merger/Acquisition Other Devices and Supplies
Discount Diabetic 15-Apr-2013 Merger/Acquisition Distributors (Healthcare)
EatWiseRx 08-Feb-2013 Merger/Acquisition Other Healthcare Services
Epocal 01-Feb-2013 Merger/Acquisition Monitoring Equipment
You’re viewing 5 of 55 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Alere ESG

Risk Overview

Risk Rating

Updated January, 07, 2025

21.62 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Alere’s complete esg history, request access »

Alere Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Twistdx Maidenhead, United Kingdom 1999
Axis-Shield Dundee, United Kingdom 1993
European Drug Testing Service Kista, Sweden 1991
Abbott Toxicology Gretna, LA 1978

Alere FAQs

  • When was Alere founded?

    Alere was founded in 1981.

  • Where is Alere headquartered?

    Alere is headquartered in Waltham, MA.

  • What is the size of Alere?

    Alere has 10,000 total employees.

  • What industry is Alere in?

    Alere’s primary industry is Diagnostic Equipment.

  • Is Alere a private or public company?

    Alere is a Private company.

  • What is the current valuation of Alere?

    The current valuation of Alere is .

  • What is Alere’s current revenue?

    The current revenue for Alere is .

  • How much funding has Alere raised over time?

    Alere has raised $2.38B.

  • Who are Alere’s investors?

    Crawley Ventures, Optum, and Skywood Ventures have invested in Alere.

  • Who are Alere’s competitors?

    Curetis, CapeRay, BioGenex Laboratories, Heska, and ELITechGroup are some of the 20 competitors of Alere.

  • When was Alere acquired?

    Alere was acquired on 03-Oct-2017.

  • Who acquired Alere?

    Alere was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »